For more than 50 years, The Lubrizol Corporation, a Berkshire Hathaway company, has been a global producer of high performing excipients for solid, semisolid, and liquid dosage forms used in oral and topical applications. Lubrizol excipients are used in both prescription and over-the-counter drug products to impart valuable functional benefits such as bioadhesion, controlling drug release from tablets, and improving flow properties in semisolid and liquid formulations. A technology-driven global company, Lubrizol combines complex, specialty chemicals to optimize the quality, performance and value customers require while reducing their environmental impact.